It’s the perfect holiday gift: the ability to treat a painful condition without medication.
Phimosis is a condition where the skin is too thin to accommodate the fluid needed to fill it.
For some, the condition can be triggered by a viral infection, or it can result from a birth defect.
In Ontario, people who have been diagnosed with phimotics are eligible for $5,000 in financial assistance for care, including a monthly prescription.
But in B.C., where Ixeda’s medical marijuana dispensary is located, the patient must be diagnosed with a severe phimotism, a condition that causes a swelling or loss of skin that can cause discomfort or infection.
In B.CA., the government says its program provides $2,500 to $5.50 per month for “non-serious” phimoroses, and $1,500 per month to $2 per month per patient for “serious” ones.
The B.CN. said its program is aimed at people with severe or chronic phimotos, who are more likely to benefit from the program than those who have a mild or moderate condition.
The province’s medical cannabis program, which began in January, is the largest medical marijuana program in North America, said Minister of Health and Long-Term Care David Eby.
In the first phase of its rollout, medical cannabis dispensaries in B-line locations will receive 10 applications a day.
At the start of this year, the B.
said there were a total of 1,819 applications.
It said the province’s initial target of 7,000 medical cannabis patients a year is not realistic and will be adjusted depending on demand.
In 2019, the government hopes to have 5,000 patients a day eligible for financial assistance.
“We’ve heard the feedback from the community and we know there are those who don’t have access to cannabis, those who are currently unable to access cannabis because of health conditions,” Eby said.
The government has also set up a toll-free number for people with questions about cannabis, and a website where people can find out if they qualify for financial help.
“It’s about the patients,” said Eby, who also heads the provincial government’s cannabis advisory committee.
“The province has been working with the provinces and territories to ensure access to medical cannabis.”
For now, Eby says patients are being provided with the same options as everyone else.
The number of applications is expected to drop over the coming months as the province continues to refine its program, said Eberhart.
The Ixda Medical Marijuana dispensary in Bancroft, B.
Com., will have to close by March, according to a spokesperson.
But the company will continue to be available for the next few months.
The program is available to people who are medically diagnosed with the condition.
Ixida’s CEO, Matt Deere, said the dispensary will continue with its operations while it looks for other locations to continue their business.
In 2018, the province began allowing medical marijuana for adults over the age of 18.
The program, administered through the Bancros and the BCA, has a cap of $1.6 million a year, and the government plans to gradually increase that number to $3.4 million in 2020.
“If we’re able to get to that point of $4 million, then we’ll be able to make the next step to establish a network of dispensaries, and that will help us grow the business,” Deere said.
“But we’re not there yet.”